» Articles » PMID: 38225233

ZBTB7B is a Permissive Regulator of Hepatocellular Carcinoma Initiation by Repressing C-Jun Expression and Function

Overview
Journal Cell Death Dis
Date 2024 Jan 15
PMID 38225233
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocarcinogenesis is a multi-step process. However, the regulators of hepatocellular carcinoma (HCC) initiation are understudied. Adult liver-specific gene expression was globally downregulated in HCC. We hypothesize that adult liver-specific genes, especially adult liver-enriched transcription factors may exert tumor-suppressive functions in HCC. In this study, we identify ZBTB7B, an adult liver-enriched transcription factor as a permissive regulator of HCC initiation. ZBTB7B is highly expressed in hepatocytes in adult livers, compared to fetal livers. To evaluate the functions of ZBTB7B in hepatocarcinogenesis, we performed hepatocyte-specific ZBTB7B knockout in hydrodynamic oncogene transfer-induced mouse liver cancer models. Hepatocyte-specific knockout of ZBTB7B promotes activated Akt and N-Ras-induced HCC development. Moreover, ZBTB7B deficiency sensitizes hepatocytes to a single oncogene Akt-induced oncogenic transformation and HCC initiation, which is otherwise incompetent in inducing HCC. ZBTB7B deficiency accelerates HCC initiation by down-regulating adult liver-specific gene expression and priming livers to a fetal-like state. The molecular mechanism underlying ZBTB7B functions in hepatocytes was investigated by integrated transcriptomic, phosphoproteomic, and chromatin immunoprecipitation-sequencing analyses. Integrative multi-omics analyses identify c-Jun as the core signaling node in ZBTB7B-deficient liver cancer initiation. c-Jun is a direct target of ZBTB7B essential to accelerated liver cancer initiation in ZBTB7B-deficient livers. Knockdown of c-Jun expression or dominant negative c-Jun expression delays HCC development in ZBTB7B-deficient livers. In addition, ZBTB7B competes with c-Jun for chromatin binding. Ectopic ZBTB7B expression attenuates the tumor-promoting functions of c-Jun. Expression of ZBTB7B signature, composed of 140 genes co-regulated by ZBTB7B and c-Jun, is significantly downregulated in early-stage HCCs compared to adjacent normal tissues, correlates to liver-specific gene expression, and is associated with good prognosis in human HCC. Thus, ZBTB7B functions as a permissive regulator of HCC initiation by directly regulating c-Jun expression and function.

Citing Articles

Zbtb7b defines a compensatory mechanism in MASLD-related HCC progression by suppressing H19-mediated hepatic lipid deposition.

Han Y, Wu K, Peng X, Fu Y, Li W, Ma J Physiol Rep. 2024; 12(24):e70160.

PMID: 39714087 PMC: 11664540. DOI: 10.14814/phy2.70160.

References
1.
Vacchio M, Wang L, Bouladoux N, Carpenter A, Xiong Y, Williams L . A ThPOK-LRF transcriptional node maintains the integrity and effector potential of post-thymic CD4+ T cells. Nat Immunol. 2014; 15(10):947-56. PMC: 4251968. DOI: 10.1038/ni.2960. View

2.
Zhang R, Ma H, Gao Y, Wu Y, Qiao Y, Geng A . Th-POK regulates mammary gland lactation through mTOR-SREBP pathway. PLoS Genet. 2018; 14(2):e1007211. PMC: 5821406. DOI: 10.1371/journal.pgen.1007211. View

3.
Smith J, FRANCIS T, EDINGTON G, Williams A . Immunofluorescent localisation of human alpha feto-protein in fetal and neonatal livers and cultured cells from hepatocellular carcinoma. Br J Cancer. 1971; 25(2):343-9. PMC: 2008448. DOI: 10.1038/bjc.1971.44. View

4.
Chen X, Cheung S, So S, Fan S, Barry C, Higgins J . Gene expression patterns in human liver cancers. Mol Biol Cell. 2002; 13(6):1929-39. PMC: 117615. DOI: 10.1091/mbc.02-02-0023. View

5.
Russo-Savage L, Schulman I . Liver X receptors and liver physiology. Biochim Biophys Acta Mol Basis Dis. 2021; 1867(6):166121. PMC: 9242550. DOI: 10.1016/j.bbadis.2021.166121. View